Esperion Therapeutics (ESPR) Tops Q2 EPS by 15c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Esperion Therapeutics (ESPR) Tops Q2 EPS by 15c

Northland Upgrades Esperion Therapeutics (ESPR) to Market Perform. 'Potential Resolution of DSE Litigation as Catalysts'

August 1, 2023 2:01 PM EDT

Northland Capital Markets analyst Carl Byrnes upgraded Esperion Therapeutics (NASDAQ: ESPR) from Underperform to Market Perform with a price target of $2.00 (from $1.00).

The analyst comments "We are adjusting our rating to MP as we believe sNDA approvals in both the... More